October 2019 | Volume 18 | Issue 10 | Features | 1064 | Copyright © October 2019

Upcoming news
ACZONE® (Dapsone) Gel, 7.5% Now Approved for the Topical Treatment of Acne Vulgaris in Patients 9 Years of Age and Older

Almirall LLC announced today the FDA approval of the expanded indication for Aczone® 7.5% Gel to include patients aged 9-11. Aczone® 7.5% Gel is a prescription medicine used on the skin (topical) to treat inflammatory and non-inflammatory acne, previously approved in February 2016 for patients 12 and older. The expanded approval was based on data from an open-label safety study to assess safety, pharmacokinetics, and treatment effect of Aczone® Gel, 7.5% in 101 patients 9 to 11 years of age with acne vulgaris. Aczone® 7.5% Gel was determined to be safe and effective in this patient population.

Destination: Healthy Skin, The Skin Cancer Foundation’s Mobile Education and Screening Program, Concludes Another Trip Around the Country

Destination: Healthy Skin, The Skin Cancer Foundation’s mobile skin cancer education and screening program, has wrapped its third annual journey around the U.S. Local volunteer dermatologists conducted 1,827 free skin cancer screenings aboard the Foundation’s 38-foot Destination: Healthy Skin RV. Program participants also received The Skin Cancer Foundation’s educational materials and sun protection samples.

The Destination: Healthy Skin RV traveled more than 10,000 miles between May and August, making stops for educational events in New York, Florida, Louisiana, Texas, Arizona, California, Utah, Colorado, Nebraska, Illinois, Indiana, Kentucky, Tennessee and Connecticut. Together, 59 dermatologists teamed up to donate more than 175 hours of free, full-body skin exams at Destination: Healthy Skin events. The dermatologists identified 578 potential skin cancers and precancers, 40 of which were suspected melanomas.

The Skin Cancer Foundation Launches Redesigned Website

The Skin Cancer Foundation has redesigned its website to ease navigation and provide visitors with an improved user experience.

The Foundation takes its responsibility as the leader in skin cancer patient education very seriously. Nearly 9 million people visit SkinCancer.org annually, and the organization continually strives to improve the online resources it has to offer. SkinCancer.org is a major portal through which patients and caretakers can educate themselves about skin cancer treatment options, and the general public can learn about prevention by means of sun protection and the importance of early detection.